IMMUSOFT

Immusoft is a biotechnology company that is commercializing technology to program the human immune system by modifying the DNA in immune cells. The core components of Immusoft’s Immune System Programming (ISP) technology was developed in the Baltimore Lab at the California Institute of Technology (Caltech) and exclusively licensed by Immusoft. The technology instructs a patient’s cells to produce gene-encoded medicines (biologics). Cells that are reprogrammed using ISP become miniature drug factories that are expected to survive in patients for many years. It was founded in 2009 and is headquartered in Seattle, Washington.

#People #Financial #Website #More

IMMUSOFT

Social Links:

Linkedin

Twitter

Industry:

Biotechnology Life Science Therapeutics

Founded:

2009-01-01

Address:

Seattle, Washington, United States

Country:

United States

Website Url:

http://www.immusoft.com

Total Employee:

11+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

41.27 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins

Current Advisors List

not_available_image

Daniel F. Hoth Advisory Board @ Immusoft
Advisor

alan-leong_image

Alan Leong Advisory Board @ Immusoft
Advisor

not_available_image

Francois Loic Cosset Advisor @ Immusoft
Advisor

richard-chin_image

Richard Chin Advisory Board @ Immusoft
Advisor

william-bill-hyun_image

William (Bill) Hyun Scientific Advisor and Investor @ Immusoft
Advisor
2013-01-01

julia-moore_image

Julia Moore Board Member / Investor @ Immusoft
Board_member
2018-01-01

shelly-heimfeld_image

Shelly Heimfeld Advisor @ Immusoft
Advisor

iqbal-grewal_image

Iqbal Grewal Advisor @ Immusoft
Advisor

Current Employees Featured

jane-yoo_image

Jane Yoo
Jane Yoo Director of Research @ Immusoft
Director of Research

mei-zu_image

Mei Zu
Mei Zu Principal Scientist @ Immusoft
Principal Scientist
2019-03-01

john-z-hall_image

John Z Hall
John Z Hall Director of Operations @ Immusoft
Director of Operations

matthew-scholz_image

Matthew Scholz
Matthew Scholz CTO @ Immusoft
CTO

sean-ainsworth_image

Sean Ainsworth
Sean Ainsworth CEO & Chairman @ Immusoft
CEO & Chairman
2008-01-01

charlie-liu_image

Charlie Liu
Charlie Liu Scientist @ Immusoft
Scientist

Founder

matthew-scholz_image

Matthew Scholz

Acquisitions List

Date	Company	Article	Price
2016-03-09	Discovery Genomics	Discovery Genomics acquired by Immusoft	N/A

Investors List

california-institute-for-regenerative-medicine_image

California Institute for Regenerative Medicine

California Institute for Regenerative Medicine investment in Grant - Immusoft

breakoutventures_image

Breakout Ventures

Breakout Ventures investment in Venture Round - Immusoft

mesa-verde-venture-partners_image

Mesa Verde Venture Partners

Mesa Verde Venture Partners investment in Venture Round - Immusoft

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - Immusoft

ikarian-capital-llc_image

Ikarian Capital

Ikarian Capital investment in Venture Round - Immusoft

breakoutventures_image

Breakout Ventures

Breakout Ventures investment in Series B - Immusoft

alexandria-venture-investments_image

Alexandria Venture Investments

Alexandria Venture Investments investment in Series B - Immusoft

rbv-capital_image

RBV Capital

RBV Capital investment in Series B - Immusoft

grids-capital_image

GRIDS Capital

GRIDS Capital investment in Series B - Immusoft

mesa-verde-venture-partners_image

Mesa Verde Venture Partners

Mesa Verde Venture Partners investment in Series B - Immusoft

Official Site Inspections

http://www.immusoft.com

Host Informations
Whois Informations

Loading ...

More informations about "Immusoft" on Search Engine